Pyloric Botulinum Toxin for Diabetic Gastroparesis: A Case of Sustained Glycaemic Improvement.
TL;DR
A potential promising association between botulinum toxin injection in the pylorus and enhanced diabetic control in type 1 diabetics is examined.
OpenAlex 토픽 ·
Gastrointestinal motility and disorders
Botulinum Toxin and Related Neurological Disorders
Parkinson's Disease Mechanisms and Treatments
A potential promising association between botulinum toxin injection in the pylorus and enhanced diabetic control in type 1 diabetics is examined.
APA
Luke Bugeja, Lianne Camilleri, John Schembri (2025). Pyloric Botulinum Toxin for Diabetic Gastroparesis: A Case of Sustained Glycaemic Improvement.. European journal of case reports in internal medicine, 12(8), 005495. https://doi.org/10.12890/2025_005495
MLA
Luke Bugeja, et al.. "Pyloric Botulinum Toxin for Diabetic Gastroparesis: A Case of Sustained Glycaemic Improvement.." European journal of case reports in internal medicine, vol. 12, no. 8, 2025, pp. 005495.
PMID
40786538
Abstract
[INTRODUCTION] Diabetic gastroparesis is a gastrointestinal motility disorder defined as a delay in gastric emptying time without any mechanical obstruction. This affects about 40% of patients with type 1 diabetes and up to 30% of patients with type 2 diabetes, especially those with long-standing disease, and arises from dysfunction of the autonomic and enteric nervous systems. Unfortunately, it can cause great difficulty in controlling post-meal glucose excursions because food absorption can become unpredictable in this group of patients. Gastroparesis is therefore linked with fluctuations in glycaemic control due to variable nutrient absorption. This may worsen the extent of gastroparesis, making glucose control even more difficult. Treatment with botulinum toxin injections has been described in clinical trials with doubtful efficacy to abating symptoms associated with gastroparesis.
[CASE PRESENTATION] We report a case of how pyloric botulinum toxin injections significantly improved a patient's type 1 diabetic control and gastrointestinal symptoms associated with gastroparesis and is still maintaining improved glucose levels six months after her procedure. Although current data and case studies highlight a potential role for pyloric botulinum toxin injections, no association was found between pyloric botulinum toxin injections and blood glucose control in type 1 diabetics.
[CONCLUSION] This article examines a potential promising association between botulinum toxin injection in the pylorus and enhanced diabetic control in type 1 diabetics.
[LEARNING POINTS] Despite being a temporary intervention, pyloric botulinum toxin injection provided sustained clinical benefit in this case. The treatment significantly improved glucose control and symptoms of autonomic neuropathy in a type 1 diabetic patient. Current data lack evidence for glycaemic benefit in type 1 diabetics, highlighting the need for targeted clinical trials.
[CASE PRESENTATION] We report a case of how pyloric botulinum toxin injections significantly improved a patient's type 1 diabetic control and gastrointestinal symptoms associated with gastroparesis and is still maintaining improved glucose levels six months after her procedure. Although current data and case studies highlight a potential role for pyloric botulinum toxin injections, no association was found between pyloric botulinum toxin injections and blood glucose control in type 1 diabetics.
[CONCLUSION] This article examines a potential promising association between botulinum toxin injection in the pylorus and enhanced diabetic control in type 1 diabetics.
[LEARNING POINTS] Despite being a temporary intervention, pyloric botulinum toxin injection provided sustained clinical benefit in this case. The treatment significantly improved glucose control and symptoms of autonomic neuropathy in a type 1 diabetic patient. Current data lack evidence for glycaemic benefit in type 1 diabetics, highlighting the need for targeted clinical trials.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 7 | |
| 해부 | gastric
|
scispacy | 1 | ||
| 해부 | enteric nervous
|
scispacy | 1 | ||
| 해부 | blood glucose
|
scispacy | 1 | ||
| 해부 | pylorus
|
scispacy | 1 | ||
| 합병증 | gastrointestinal
|
scispacy | 1 | ||
| 합병증 | pyloric botulinum
|
scispacy | 1 | ||
| 약물 | glucose
|
C0017725
glucose
|
scispacy | 1 | |
| 약물 | [INTRODUCTION] Diabetic
|
scispacy | 1 | ||
| 약물 | [LEARNING POINTS]
|
scispacy | 1 | ||
| 질환 | Pyloric Botulinum
|
scispacy | 1 | ||
| 질환 | Diabetic Gastroparesis
|
C0267176
Gastroparesis due to diabetes mellitus
|
scispacy | 1 | |
| 질환 | gastrointestinal motility disorder
|
C0854121
Gastrointestinal motility disorder
|
scispacy | 1 | |
| 질환 | diabetes
|
C0011847
Diabetes
|
scispacy | 1 | |
| 질환 | type 2 diabetes
|
C0011860
Diabetes Mellitus, Non-Insulin-Dependent
|
scispacy | 1 | |
| 질환 | Gastroparesis
|
C0152020
Gastroparesis
|
scispacy | 1 | |
| 질환 | pyloric botulinum toxin
|
scispacy | 1 | ||
| 질환 | diabetic control and gastrointestinal symptoms
|
scispacy | 1 | ||
| 질환 | diabetic
|
C0241863
diabetic
|
scispacy | 1 | |
| 질환 | autonomic neuropathy
|
C0259749
Autonomic neuropathy
|
scispacy | 1 | |
| 질환 | disease
|
scispacy | 1 | ||
| 기타 | Pyloric Botulinum Toxin
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.